GTL Ltd, Add-Shop E-Retail Ltd, Vimta Labs Ltd and Savita Oil Technologies Ltd are among the other losers in the BSE’s ‘B’ group today, 30 January 2023.

Heranba Industries Ltd leads losers in ‘B’ group

Vimta Labs Consolidated December 2022 Net Sales at Rs 77.38 crore, up 14.92% Y-o-Y

Vimta Labs consolidated net profit rises 35.63% in the September 2022 quarter

To invest ₹70 cr to strengthen testing infra

VIMTA Labs forays into electrical, electronics testing

The paid-up share capital of the Company has accordingly increased from Rs. 4,42,15,620 consisting of 2,21,07,810 equity shares having a face value of Rs. 2/- each to Rs. 4,42,35,546 consisting of 2,21,17,773 equity shares having a face value of

Vimta Labs allots 9963 equity shares under ESOP

Vimta Labs’ consolidated net profit surged 44.91% to Rs 11.68 crore on a 14.77% jump in revenue from operations to Rs 67.34 crore in Q3 FY22 over Q3 FY21.

Vimta Labs Q3 PAT grows 45% YoY to Rs 12 cr

Vimta Labs consolidated net profit rises 44.73% in the December 2021 quarter

Vimta Labs standalone net profit rises 44.44% in the December 2021 quarter

Buzzing stocks: HUL, Asian Paints, Concor, Bajaj Finserv, Biocon, Havells, PNB Housing South Indian Bank, Vimta Labs, VST Ind, HCL Tech, Palred Tech, Nandan Denim, Warren Tea, Dhunseri Tea

Stocks that will see action on January 20

More than 200 stocks, including Vimta Labs, Shipping Corp and BEML, hit a 52-week high on the BSE

Taking Stock | Bloodbath On D-St! New Corona Variant Drags Market 3% Lower; Investors Lose Rs 7 Lakh Crore

MPS Infotecnics, Vimta Labs, Kabra Extrusion, JBM Auto and Universus Photo, hit their fresh 52-week highs during the day.

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Vimta Labs Limited is engaged in providing testing and contract research services in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.

Vimta Labs Ltd